AIM
MED icon

Alambic Investment Management’s Medifast MED Stock Holding History

Alambic Investment Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-5,008
Closed -$468K – 406
2018
Q1 		$468K Buy
5,008
+196
+4% +$14.6K 0.07% 327
2017
Q4 		$336K Buy
+4,812
New +$319K 0.04% 363
2017
Q2 		– Sell
-9,300
Closed -$413K – 641
2017
Q1 		$413K Sell
9,300
-2,300
-20% -$99K 0.05% 445
2016
Q4 		$483K Sell
11,600
-3,650
-24% -$147K 0.09% 337
2016
Q3 		$576K Buy
15,250
+1,750
+13% +$62.7K 0.14% 257
2016
Q2 		$449K Buy
13,500
+1,200
+10% +$38.7K 0.11% 303
2016
Q1 		$371K Sell
12,300
-3,500
-22% -$102K 0.12% 275
2015
Q4 		$480K Buy
+15,800
New +$471K 0.29% 131

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Alambic Investment Management's MED Position: Q2 2018 in Review

Alambic Investment Management sold out of Medifast (MED) in Q2 2018, closing a stake of 5,008 shares — an estimated $468K sold.

Alambic Investment Management first reported a position in MED in Q4 2015 and held it in 8 quarters. The position peaked at $576K in Q3 2016. 258 funds tracked by Wall St. Rank hold MED as of Q2 2018.

  • Alambic Investment Management reported no remaining Medifast position as of Q2 2018 after selling out during the quarter.
  • Alambic Investment Management sold 5,008 Medifast shares in Q2 2018, an estimated $468K.
  • Alambic Investment Management first reported a position in Medifast in Q4 2015 and held it in 8 quarters.
  • Alambic Investment Management's Medifast position peaked at $576K in Q3 2016.
  • 258 funds tracked by Wall St. Rank held Medifast as of Q2 2018.

Based on Alambic Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.